NEW YORK (Reuters Health) – Long-term inhalation therapy with dry-powder mannitol improves lung function in patients with cystic fibrosis (CF), a multinational team reports in the American Journal of Respiratory and Critical Care Medicine online December 28.
“The safety profile was also acceptable,...